Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report-Reference-Cited by-同舟云学术

Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report

Published:2021-12-17 Issue: Volume: Page:
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Matin Surena F.¹²,Pierorazio Phillip M.³²,Kleinmann Nir⁴,Gore John L.⁵,Shabsigh Ahmad⁶,Hu Brian⁷,Chamie Karim⁸,Godoy Guilherme⁹,Hubosky Scott G.¹⁰,Rivera Marcelino¹¹,O’Donnell Michael¹²,Quek Marcus¹³,Raman Jay D.¹⁴,Knoedler John J.¹⁴,Scherr Douglas¹⁵,Weight Christopher¹⁶,Weizer Alon¹⁷,Woods Michael¹³,Kaimakliotis Hristos¹⁸,Smith Angela B.¹⁹,Linehan Jennifer²⁰,Coleman Jonathan²¹,Humphreys Mitchell R.²²,Pak Raymond²³,Lifshitz David²⁴,Verni Michael²⁵,Klein Ifat²⁶,Konorty Marina²⁶,Strauss-Ayali Dalit²⁶,Hakim Gil²⁶,Seltzer Elyse²⁷,Schoenberg Mark²⁷²,Lerner Seth P.⁹

Affiliation:

1. Department of Urology, The University of Texas Maryland Anderson Cancer Center, Houston, Texas

2. Department of Urology, Albert Einstein College of Medicine, Bronx, New York

3. Brady Urological Institute, The Johns Hopkins University, Baltimore, Maryland

4. Department of Urology, Sheba Medical Center, Ramat Gan, Israel

5. Department of Urology, University of Washington Medical Center, Seattle, Washington

6. Department of Urology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio

7. Department of Urology, Loma Linda University, Loma Linda, California

8. Department of Urology, UCLA, Los Angeles, California

9. Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas

10. Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania

11. Department of Urology, Mayo Clinic Health System, Rochester, Minnesota

12. Department of Urology, University of Iowa, Iowa City, Iowa

13. Department of Urology, Loyola University Medical Center, Maywood, Illinois

14. Division of Urology, Pennsylvania State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania

15. Department of Urology, Weill Medical College of Cornell University, New York, New York

16. Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio

17. Department of Urology, University of Michigan, Ann Arbor, Michigan

18. Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana

19. Department of Urology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

20. Department of Urology, John Wayne Cancer Institute, Santa Monica, California

21. Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York

22. Department of Urology, Mayo Clinic-Phoenix, Scottsdale, Arizona

23. Department of Urology, Mayo Clinic-Jacksonville, Jacksonville, Florida

24. Department of Urology, Rabin Medical Center, Tel Aviv, Israel

25. Urology Center of Las Vegas, Las Vegas, Nevada

26. UroGen Pharma, Ra’anana, Israel

27. UroGen Pharma, Princeton, New Jersey

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes;European Urology Focus;2023-11

2. Intravesical Therapy for Upper Urinary Tract Urothelial Carcinoma: A Comprehensive Review;Cancers;2023-10-17

3. Modern Kidney-Sparing Management of Upper Tract Urothelial Carcinoma;Cancers;2023-09-10

4. Advances in chemoablation in upper tract urothelial carcinoma: overview of indications and treatment patterns;Translational Andrology and Urology;2023-09

5. The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma;Urologic Oncology: Seminars and Original Investigations;2023-09